Alternating pulse
Specialty: Cardiovascular.
Why it occurs
- Severe left ventricular failure (LVEF <30%)
- Advanced idiopathic or ischemic dilated cardiomyopathy
- Critical aortic stenosis in the phase of myocardial decompensation
- Paroxysmal supraventricular or sustained ventricular tachycardia
- Severe acute myocarditis with compromised contractility
Initial workup
12-lead electrocardiogram to identify signs of acute myocardial ischemia, left ventricular hypertrophy or electrical alternans (associated with tamponade); Transthoracic echocardiogram to accurately quantify ejection fraction, left ventricular end-systolic and end-diastolic volumes, and rule out valvular or obstructive structural heart disease; Invasive intra-arterial pressure monitoring (arterial line) to confirm and record beat-to-beat variation in systolic pulse pressure.
red flags
Detection of alternating pulse during arterial palpation or sphygmomanometry (regular oscillation of strong and weak beats with a constant rhythm) associated with dyspnea on minimal effort or at rest, orthopnea, anginal chest pain, syncope, arterial hypotension (SBP <90 mmHg) or profuse diaphoresis. It suggests a state of severe myocardial claudication or imminent cardiogenic shock, requiring immediate referral to an intensive care unit.
Standard management
- Levosimendan — calcium sensitizer with inotropic and vasodilator effect, indicated in the acute decompensation of severe heart failure without marked hypotension refractory to standard treatment; infusion of 0.05 to 0.2 mcg/kg/min over 24 hours
- Dobutamine — beta-adrenergic inotropic agent to improve ventricular contractility; 2 to 5 mcg/kg/min in continuous intravenous infusion, adjusting according to electrocardiographic monitoring for risk of arrhythmias
- Nitroglycerin — venous and coronary arterial vasodilator to reduce ventricular preload and afterload, useful if there is associated pulmonary congestion; infusion of 5 to 100 mcg/min, contraindicated if SBP <90 mmHg
- Furosemide (loop diuretic for the management of associated volume overload; 40 mg intravenous bolus, with reevaluation of the diuretic response at 2 and 6 hours).
Educational guidance for study. It is NOT a prescription recommendation. The actual choice depends on the cause, the patient, and current guidelines.
- Area
- Cardiovascular
- Listed causes
- 5
- Treatment options
- 4